Padagis US LLC
NDC labeler code: 0574
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- LenalidomideRevlimid · 6 products
- TretinoinRetin-A, Retin-A Micro, Altreno · 5 products
- Hydromorphone hydrochlorideDilaudid · 4 products
- MethylphenidateMetadate Cd, Relexxii, Methylphenidate Hydrochloride Cd · 4 products
- Benazepril hydrochloride and hydrochlorothiazideLotensin Hct · 2 products
- PodofiloxCondylox · 2 products
- Testosterone cypionateDepo-Testosterone, Azmiro · 2 products
- Trospium chloride2 products
- Loteprednol etabonateLotemax, Lotemax Sm, Alrex · 2 products
- Methazolamide2 products
- Lidocaine and prilocaineOraqix · 1 product
- Tobramycin and dexamethasoneTobradex St, Tobradex · 1 product
- Bromocriptine mesylateCycloset · 1 product
- Amiloride1 product
- TofacitinibXeljanz, Xeljanz XR · 1 product
- NystatinNystop, Klayesta, Nyamyc · 1 product
- BudesonidePulmicort Flexhaler, Pulmicort Respules, Uceris · 1 product
- Ciclopirox1 product
- ClotrimazoleClotic (Clotrimazole) Otic Solution · 1 product
- AcetylcysteineAcetadote · 1 product
- Brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide1 product
- SpironolactoneAldactone · 1 product
- PhytonadioneVitamin K1 · 1 product
- BrinzolamideAzopt · 1 product
- Flavoxate hydrochloride1 product
- MidazolamNayzilam · 1 product
- EstradiolEstradiol Vaginal, Dotti, Estradiol Transdermal System · 1 product
- ProchlorperazineCompro · 1 product
- ParoxetinePaxil, Paxil CR, Brisdelle · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| February 26, 2026 | ANDA220454 | Phytonadione PHYTONADIONE | Novax |
| September 30, 2025 | ANDA216001 | Tofacitinib TOFACITINIB CITRATE | Sinotherapeutics Inc |
| January 29, 2025 | ANDA215204 | Loteprednol etabonate LOTEPREDNOL ETABONATE | Padagis Us |
| July 10, 2024 | ANDA215203 | Loteprednol etabonate LOTEPREDNOL ETABONATE | Padagis Us |
| February 22, 2024 | ANDA217265 | Lenalidomide LENALIDOMIDE | Qilu |
| November 22, 2023 | ANDA211871 | Podofilox PODOFILOX | Padagis Us |
| July 28, 2023 | ANDA211914 | Brinzolamide BRINZOLAMIDE | Padagis Us |
| February 11, 2022 | ANDA212715 | Tobramycin and dexamethasone TOBRAMYCIN AND DEXAMETHASONE | Padagis Us |
| July 27, 2021 | ANDA212482 | Lidocaine and prilocaine LIDOCAINE AND PRILOCAINE | Padagis Us |
| August 4, 2017 | NDA209478 | Spironolactone CAROSPIR | Cmp Dev LLC |
| April 6, 2015 | ANDA204278 | Hydromorphone hydrochloride HYDROMORPHONE HYDROCHLORIDE | Padagis Us |
| July 15, 2014 | ANDA205292 | Brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | Padagis Us |
| June 28, 2013 | NDA204516 | Paroxetine BRISDELLE | Legacy |
| May 24, 2013 | ANDA201291 | Trospium chloride TROSPIUM CHLORIDE | Padagis Us |
| May 1, 2012 | ANDA091244 | Testosterone cypionate TESTOSTERONE CYPIONATE | Hikma Farmaceutica |
| November 17, 2010 | ANDA091573 | Trospium chloride TROSPIUM CHLORIDE | Padagis Us |
| January 7, 2009 | ANDA078266 | Ciclopirox CICLOPIROX | Padagis Us |
| October 1, 2008 | ANDA077646 | Bromocriptine mesylate BROMOCRIPTINE MESYLATE | Padagis Us |
| July 27, 2007 | NDA022014 | Estradiol EVAMIST | Padagis Us |
| April 6, 2006 | NDA021514 | Methylphenidate DAYTRANA | Noven Pharms Inc |
| October 28, 2005 | ANDA076763 | Clotrimazole CLOTRIMAZOLE | Padagis Us |
| May 2, 2005 | ANDA076379 | Midazolam MIDAZOLAM HYDROCHLORIDE | Padagis Us |
| January 31, 2005 | ANDA040530 | Testosterone cypionate TESTOSTERONE CYPIONATE | Padagis Us |
| December 16, 2004 | ANDA076831 | Flavoxate hydrochloride FLAVOXATE HYDROCHLORIDE | Padagis Us |
| January 23, 2004 | NDA021539 | Acetylcysteine ACETADOTE | Apotex |
Show the other 12 applications
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| June 11, 2002 | ANDA075589 | Tretinoin TRETINOIN | Padagis Us |
| January 29, 2002 | ANDA075600 | Podofilox PODOFILOX | Padagis Us |
| October 2, 2001 | NDA021324 | Budesonide ENTOCORT EC | Padagis Us |
| June 28, 2000 | ANDA040246 | Prochlorperazine COMPRO | Padagis Us |
| February 22, 2000 | ANDA075529 | Tretinoin TRETINOIN | Padagis Us |
| December 24, 1998 | ANDA075213 | Tretinoin TRETINOIN | Padagis Us |
| December 24, 1998 | ANDA075264 | Tretinoin TRETINOIN | Padagis Us |
| December 24, 1998 | ANDA075265 | Tretinoin TRETINOIN | Padagis Us |
| August 16, 1996 | ANDA064118 | Nystatin NYSTOP | Padagis Us |
| January 27, 1994 | ANDA040062 | Methazolamide METHAZOLAMIDE | Pharmobedient |
| May 19, 1992 | NDA020033 | Benazepril hydrochloride and hydrochlorothiazide LOTENSIN HCT | Validus Pharms |
| October 5, 1981 | NDA018200 | Amiloride MIDAMOR | Padagis Us |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2023
-
November 1, 2023 · Class II · Ongoing · D-0139-2024 · Trospium chloride
Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand,
-
February 21, 2023 · Class III · Ongoing · D-0464-2023 · Estradiol
Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.
Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-dose pump, Rx Only, Manufactured by DPT Laboratories, Ltd San Antonio, TX 78215, Manufactured for: Perrigo, Allegan,
2021
-
March 15, 2021 · Class II · Terminated · D-0549-2021 · Podofilox
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Podofilox Topical Solution 0.5% 3.5ML, Rx Only, For Topical Use Only, Manufactured by Perrigo, Minneapolis, MN 55427, NDC 0574-0611-05.
2018
-
February 26, 2018 · Class II · Terminated · D-0608-2018 · Estradiol
Defective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense product.
Evamist (estradiol transdermal spray), 1.53mg estradiol/spray, 0.27 fl oz (8.1 mL) per bottle, Rx Only, Manufactured for Perrigo, Minneapolis, MN 55427. NDC: 0574-2067-27
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026